Skip to main content
SpringerLink
Log in

Inhalation Therapy during Mechanical Ventilation

  • Conference paper
Intensive Care Medicine

Abstract

Aerosol medications are commonly used in mechanically ventilated patients. Several classes of drugs with different properties and indications may be given by inhalation. In all cases, compared to the systemic route, inhaled therapy has the advantage that for a given therapeutic response, the drug dose is several-fold lower, while systemic absorption is negligible, thus, greatly minimizing the side effects. In addition, for some medications the systemic route either causes non-acceptable side effects or results in considerably inferior therapeutic response, rendering the inhaled route the method of choice of drug administration. Bronchodilators, corticosteroids, vasoactive drugs, surfactant, antibiotics, helium, and perfluorocarbons are the medications that can be given by inhalation during mechanical ventilation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dhand R, Tobin MJ (1997) Inhaled bronchodilator therapy in mechanically ventilated patients. Am J Respir Crit Care Med 156: 3–10

    Article  PubMed  CAS  Google Scholar 

  2. Kondili E, Georgopoulos D (2002) Aerosol medications. Respir Care Clin 8: 309–334

    Article  Google Scholar 

  3. Mouloudi E, Katsanoulas K, Anastasaki M, Hoing S, Georgopoulos D (1999) Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of tidal volume. Intensive Care Med 25: 1215–1221

    Article  PubMed  CAS  Google Scholar 

  4. Mouloudi E, Katsanoulas K, Anastasaki M, Askitopoulou E, Georgopoulos D (1998) Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of end-inspiratory pause. Eur Respir J 12: 165–169

    Article  PubMed  CAS  Google Scholar 

  5. Mouloudi E, Prinianakis G, Kondili E, Georgopoulos D (2000) Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of flow pattern. Eur Respir J 16: 263–268

    Article  PubMed  CAS  Google Scholar 

  6. Mouloudi E, Prinianakis G, Kondili E, Georgopoulos D (2001) Effect of inspiratory flow rate on beta2-agonist induced bronchodilation in mechanically ventilated COPD patients. Intensive Care Med 27: 42–46

    Article  PubMed  CAS  Google Scholar 

  7. Mouloudi E, Malliotakis Ch, Kondili E, Kafetzakis A, Georgopoulos D (2001) Duration of salbutamol-induced bronchodilation delivered by meter-dose inhaler in mechanically ventilated patients with chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 56: 189–194

    PubMed  CAS  Google Scholar 

  8. Duarte AG, Momi K, Bidani A (2000) Bronchodilator therapy with metered-dose inhaler and spacer versus nebulizer in mechanically ventilated patients: comparison of magnitude and duration of response. Respir Care 45: 817–823

    PubMed  CAS  Google Scholar 

  9. Crandall ED, Matthay MA (2001) Alveolar epithelial transport. Basic science to clinical medicine. Am J Respir Crit Care Med 163: 1021–1029

    Google Scholar 

  10. Ware LB, Matthay MA (2001) Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 163: 1376–1383

    Article  PubMed  CAS  Google Scholar 

  11. Berthiaume Y, Staub NC, Matthay MA (1987) Beta-adrenergic agonists increase lung liquid clearance in anesthetized sheep. J Clin Invest 79: 335–343

    Article  PubMed  CAS  Google Scholar 

  12. Frank JA, Wang Y, Osorio O, Matthay MA (2000) Beta-adrenergic agonist therapy the resolution of hydrostatic pulmonary edema in sheep and rats. J Appl Physiol 89: 1255–1265

    PubMed  CAS  Google Scholar 

  13. Garat C, Meignan M, Matthay MA, Luo DF, Jayr C (1997) Alveolar epithelial fluid clearance mechanisms are intact after moderate hyperoxic lung injury in rats. Chest 111: 1381–1388

    Article  PubMed  CAS  Google Scholar 

  14. Sakuma T, Folkesson HG, Suzuki S, Okaniwa G, Fujimura S, Matthay MA (1997) Betaadrenergic agonist stimulated alveolar fluid clearance in ex vivo human and rat lungs. Am J Respir Grit Care Med 155: 506–512

    Article  CAS  Google Scholar 

  15. Verghese GM, Ware LB, Matthay BA, Matthay MA (1999) Alveolar epithelial fluid transport and the resolution of clinically severe hydrostatic pulmonary edema. J Appl Physiol 87: 1301–1312

    PubMed  CAS  Google Scholar 

  16. Atabai K, Ware LB, Snider ME, et al (2002) Aerosolized ß2-adrenergic agonists achieve therapeutic levels in the pulmonary edema fluid of ventilated patients with acute respiratory failure. Intensive Care Med 28: 705–711

    Article  PubMed  Google Scholar 

  17. Rubini F, Rambulla C, Nava S (1994) Acute effect of corticosteroids on respiratory mechanics in mechanically ventilated patients with chronic airflow obstruction and acute respiratory failure. Am J Respir Crit Care Med 149: 306–310

    Article  PubMed  CAS  Google Scholar 

  18. Nava S, Compagnoni ML (2000) Controlled short-term trial of fluticasone propionate in ventilator-dependent patients with COPD. Chest 118: 990–999

    Article  PubMed  CAS  Google Scholar 

  19. Moore RD, Smith CR, Lietman PS (1984) Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia. Am J Med 77: 657–662

    Article  PubMed  CAS  Google Scholar 

  20. Pennington JE (1981) Penetration of antibiotics into respiratory secretions. Rev Infect Dis 3: 67–73

    Article  PubMed  CAS  Google Scholar 

  21. Rouby JJ, Poète P, Martin de Lassale E, et al (1994) Prevention of Gram negative nosocomial bronchopneumonia by intratracheal colistin in critically ill patients. Histologic and bacteriologic study. Intensive Care Med 20: 187–192

    Google Scholar 

  22. Klastersky J, Geuning C, Mouawad E, Daneau D (1972) Endotracheal gentamicin in bronchial infections in patients with tracheostomy. Chest 61: 117–120

    Article  PubMed  CAS  Google Scholar 

  23. Ilowite JS, Gorvoy JD, Smaldone GC (1987) Quantitative deposition of aerosolized gentamicin in cystic fibrosis. Am Rev Respir Dis 136: 1445–1449

    Article  PubMed  CAS  Google Scholar 

  24. Goldstein I, Wallet F, Robert J, et al (2002) Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs. Am J Respir Crit Care Med 165: 171–175

    Article  PubMed  Google Scholar 

  25. Palmer LB, Smaldone GC, Simon SR, O’Riordan TG, Cuccia A (1998) Aerosolized antibiotics in mechanically ventilated patients: delivery and response. Crit Care Med 26: 31–39

    Article  PubMed  CAS  Google Scholar 

  26. Barker AF, Couch L, Fiel SB, et al (2000) Tobramycin solution for inhalation reduces sputum Pseudomonas aeroginosa density in bronchiectacis. Am J Respir Crit Care Med 162: 481–485

    Article  PubMed  CAS  Google Scholar 

  27. Zimmerman JL, Hanania NA (1998) Vasodilators in mechanical ventilated patients. Crit Care Clin 14: 611–627

    Article  PubMed  CAS  Google Scholar 

  28. McIntyre RC, Pulido EJ, Bensard DD, Gotfriedet MA, Ilowite J, Meyer KC (2000) Thirty years of clinical trials in acute respiratory distress syndrome. Crit Care Med 28: 3314–3331

    Article  PubMed  CAS  Google Scholar 

  29. Puybasset L, Roudyt JJ, Mourgeon E, et al (1995) Factors influencing cardiopulmonary effects of inhaled nitric oxide in acute respiratory failure. Am J Respir Crit Care 152: 318–328

    Article  CAS  Google Scholar 

  30. Christenson J, Lavoie A, O’Connor M, Bhorade S, Pohlman A, Hall JB (2000) The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide. Am J Respir Crit Care Med 161: 1443–1449

    Article  PubMed  CAS  Google Scholar 

  31. Domenighetti G, Stricker H, Waldispuehl B (2001) Nebulized prostacyclin in acute respiratory distress syndrome: impact of primary (pulmonary injury) and secondary (extrapulmonary injury) disease on gas exchange response. Crit Care Med 29: 57–62

    Article  PubMed  CAS  Google Scholar 

  32. Muller B, Schmidtke M, Witt W (1987) Action of the stable prostacyclin analogue iloprost on microvascular tone and permeability in the hamster cheek pouch. Prostaglandins Leukot Med 29: 187–198

    Article  PubMed  CAS  Google Scholar 

  33. Gregory TJ, Longmore WJ, Moxley MA, et al (1991) Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 88: 1976–1981

    Article  PubMed  CAS  Google Scholar 

  34. Lewis JF, Jobe AH (1993) Surfactant in adult respiratory distress syndrome. Am Rev Respir Dis 147: 218–233

    Article  PubMed  CAS  Google Scholar 

  35. Vazquez de GF, Lachmann RA, Gommers D, Verbrugge SJ, Haitsma J, Lachmann B (2001) Treatment of ventilation-induced lung injury with exogenous. Intensive Care Med 27: 559565

    Google Scholar 

  36. Haitsma JJ, Uhlig S, Lachmann U, Verbrugge SJ, Poelma DL, Lachmann B (2002) Exogenous surfactant reduces ventilator-induced decompartmentalization of tumor necrosis factor alpha in absence of positive end - expiratory pressure. Intensive Care Med 28: 11311137

    Google Scholar 

  37. Frerking I, Gunther A, Seeger W, P Ison U (2001) Pulmonary surfactant: functions abnormalities and therapeutic options. Intensive Care Med 27: 1699–1717

    Article  PubMed  CAS  Google Scholar 

  38. Schermuly R, Gunther F, Weissmann N, et al (2000) Differential impact of ultrasonic nebulized versus instilled surfactant on ventilation perfusion mismatch V A/Q) in a model of acute lung injury. Am J Respir Crit Care Med 16: 152–159

    Article  Google Scholar 

  39. Anzueto A, Baughman RP, Kalpalatha K, et al (1996) Aerosolized surfactant in adults with sepsis–induced acute respiratory distress syndrome. N Engl J Med 334: 1417–1422

    Article  PubMed  CAS  Google Scholar 

  40. Kerr CL, Ito Y, Manwell SE, et al (1998) Effects of surfactant distribution and ventilation strategies on the efficacy of exogenous surfactant. J Appl Physiol 85: 676–684

    PubMed  CAS  Google Scholar 

  41. Tassaux D, Jolliet P, Roeseler J, Chevrolet JC (2000) Effects of helium-oxygen on intrinsic positive end-expiratory pressure in intubated and mechanicalventilated patients with severe chronic obstructive pulmonary disease. Crit Care Med 28: 2721–2728

    Article  PubMed  CAS  Google Scholar 

  42. Jaber S, Fodil R, Carlucci A, et al (2000) Noninvasive ventilation with helium-oxygen in acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161: 1191–1200

    Article  PubMed  CAS  Google Scholar 

  43. Jaber S, Carlucci A, Boussarsar M, et al (2001) Heliox–oxygen in the postextubation period decreases inspiratory effort. Am J Respir Crit Care Med 164: 633–637

    Article  PubMed  CAS  Google Scholar 

  44. Goode ML, Fink JB, Dhand R, Tobin MJ (2001) Improvement in aerosol delivery with helium-oxygen mixtures during mechanical ventilation. Am J Respir Crit Care Med 163: 109–114

    Article  PubMed  CAS  Google Scholar 

  45. Tassaux D, Jolliet P, Thouret JM, Roeseler J, Dorne R, Chervolet JC (1998) Calibration of seven ICU ventilators for mechanical ventilation with helium-oxygen mixtures. Crit Care Med 26: 290–295

    Article  Google Scholar 

  46. Hirschl R, Pranikoff R, Wise C, et al (1996) Initial experience with partial liquid ventilation in adult patients with the acute respiratory distress syndrome. JAMA 275: 383–389

    Article  PubMed  CAS  Google Scholar 

  47. Kandler M, von der Hardt I, Schoof E, Dotsch J, Rascher W (2001) Persistent improvement of gas exchange and lung mechanics by aerosolized perfluorocarbon. Am J Respir Crit Care Med 164: 31–35

    Article  PubMed  CAS  Google Scholar 

  48. Hubler M, Souders JE, Shade ED, Polissar NL, Schimmel C, Hlastala MP (2001) Effects of vaporized perfluorocarbon on pulmonary blood flow and ventilation /perfusion distribution in a model of acute respiratory distress syndrome. Anesthesiology 95: 1414–1421

    Article  PubMed  CAS  Google Scholar 

  49. Bleyl J, Ragaller M, Tscho U, et al (1999) Vaporized perfluorocarbon improves oxygenation and pulmonary function in an ovine model of acute respiratory distress syndrome. Anesthesiology 91: 461–469

    Article  PubMed  CAS  Google Scholar 

  50. Davis MW, Dunster KR (2002) Effect of perfluorocarbon (perflurooctyl bromide) vapor on tidal volume measurement during partial liquid ventilation. Crit Care Med 30: 1123–1125

    Article  Google Scholar 

Download references

Authors
  1. E. Kondili
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Alexopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Georgopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Intensive Care, Erasme Hospital, Free University of Brussels, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean-Louis Vincent MD, PhD, FCCM, FCCP (Head) (Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Kondili, E., Alexopoulou, C., Georgopoulos, D. (2003). Inhalation Therapy during Mechanical Ventilation. In: Vincent, JL. (eds) Intensive Care Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-5548-0_30

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-5548-0_30

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4757-5550-3

  • Online ISBN: 978-1-4757-5548-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation